CRSP · Categories · Form 3

CRSP - SEC Form 3 initial insider statements

CRISPR Therapeutics AG (CRSP) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for CRSP

• 326d
  Amendment: New insider Morrison Briggs claimed ownership of 5,209 shares (SEC Form 3)

  3/A - CRISPR Therapeutics AG (0001674416) (Issuer)
• 330d
  SEC Form 3 filed by new insider Morrison Briggs

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 702d
  SEC Form 3 filed by new insider Mahatme Sandesh

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 702d
  SEC Form 3 filed by new insider Rommel Christian

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 709d
  New insider Bruno Julianne claimed ownership of 10,199 shares (SEC Form 3)

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 1145d
  SEC Form 3 filed by new insider Prasad Raju

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 1422d
  SEC Form 3 filed by new insider Fardis Maria

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 1440d
  SEC Form 3 filed by new insider Morrow Phuong Khanh

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 1660d
  SEC Form 3 filed by new insider Smith Brendan

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)
• 1783d
  SEC Form 3 filed by Fleming Harold Edward

  3 - CRISPR Therapeutics AG (0001674416) (Issuer)

Other CRSP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends